GeneBio Systems
Recombinant HSD17B1 Monoclonal Antibody
Recombinant HSD17B1 Monoclonal Antibody
SKU:AN301846L
Couldn't load pickup availability
Size::50μL
Storage:Store at -20℃ Valid for 12 months. Avoid freeze / thaw cycles.
Shipping:Ice bag
Exp date:12 months
Category ID_II:Primary Antibodies
Category ID_III:Monoclonal Antibodies;Recombinant Antibodies
Abbreviation:HSD17B1
Target Synonym:HSD;EDHB;HSD17B;SDR28C;HSD17B1;17-beta-HSD;20-alpha-HSD;E2DH;EDH17B2;EDHB17;HSD17;SDR28C1;E17KSR;EDH17B1;17 beta HSD 1;17 beta hydroxysteroid dehydrogenase type 1;17-beta-HSD 1;17-beta-hydroxysteroid dehydrogenase type 1;20 alpha-hydroxysteroid dehydrogenase;DHB1;Estradiol 17 beta dehydrogenase 1;Estradiol 17-beta-dehydrogenase 1;Hydroxysteroid (17 beta) dehydrogenase 1;member 1;MGC13814;Placental 17 beta hydroxysteroid dehydrogenase;Placental 17-beta-hydroxysteroid dehydrogenase;Short chain dehydrogenase/reductase family 28CE
Research Areas:Signal Transduction;Neuroscience;Cancer;Metabolism
Conjugation:Unconjugated
Host:Rabbit
Species reactivity:Human;
Application:WB;IHC
Isotype:IgG,κ
Clonality:Monoclonal;Recombinant
Clone NO.:A558
UNIProt ID:P14061
Accession:
Background:HSD17B1 is a member of the 17beta-hydroxysteroid dehydrogenase family of short-chain dehydrogenases/reductases. It has a dual function in estrogen activation and androgen inactivation and plays a major role in establishing the estrogen E2 concentration gradient between serum and peripheral tissues. HSD17B1 catalyzes the last step in estrogen activation, using NADPH to convert estrogens E1 and E2 and androgens like 4-androstenedione, to testosterone. It has an N-terminal short-chain dehydrogenase domain with a cofactor binding site, and a narrow, hydrophobic C-terminal domain with a steroid substrate binding site. HSD17B1 is expressed primarily in the placenta and ovarian granulosa cells, and to a lesser extent, in the endometrium, adipose tissue, and prostate.
Concentration:1 mg/mL
Immunogen:Recombinant human HSD17B1 fragment
Buffer:PBS, 50% glycerol, 0.05% Proclin 300, 0.05% protein protectant.
Purification method:Protein A purified
Dilution:WB 1:5000-1:20000;IHC 1:1000-1:5000
Calculated MW:35 kDa
ObservedMW:35 kDa
